JBC INTERFERin siRNA transfection reagent

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Faber, M.
Right arrow Articles by Sealy, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Faber, M.
Right arrow Articles by Sealy, L.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

J. Biol. Chem., Vol. 265, Issue 36, 22243-22254, 12, 1990

Rous sarcoma virus enhancer factor I is a ubiquitous CCAAT transcription factor highly related to CBF and NF-Y

M Faber and L Sealy
Department of Molecular Physiology and Biophysics, Vanderbilt University School of Medicine, Nashville, Tennessee 37232.

We have characterized enhancer factor I (EFI), a trans-acting factor present in avian nuclear extracts which binds to the Rous sarcoma virus long terminal repeat enhancer and promoter. Through deletion and point mutagenesis, we show that EFI is a member of the CCAAT family of transcription factors. Although the CCAAT motif is essential for protein-DNA recognition, EFI shows surprising latitude in the nucleotide sequences flanking the CCAAT motif to which it will bind with high affinity. EFI will cross-bind to the binding sites of a number of previously described CCAAT factors, including CBF, NF-Y, CP2, CP1, CTF/NF-1, and c/EBP, with a range of affinities that is at most 10- fold lower than the high affinity binding site for EFI in the Rous sarcoma virus long terminal repeat. We present evidence, however, that EFI is probably identical or very closely related to CBF and NF-Y. This is based on the fact that EFI in avian nuclear extracts binds with equal or 2-fold greater affinity to the binding sites of NF-Y and CBF, despite less than 50% homology (outside the CCAAT motif) between the EFI, NF-Y, and CBF recognition sequences. Moreover, radiolabeled EFI, NF-Y, or CBF DNAs give rise to identical gel retardation patterns in extracts from a variety of different cell types. EFI, CBF, and NF-Y appear to fractionate identically upon ion exchange chromatography, separating into two heterologous components (A and B) which must be recombined to recover substantial DNA binding activity. Molecular weight estimates for the two heterologous components of EFI, CBF, and a Y-box binding protein (Celada, A., and Maki, R.A. (1989) Mol. Cell. Biol. 9, 3097-3100) are very similar. EFI DNA binding activity has recently been shown to be induced by serum and the oncogene v-src (Dutta, A., Stoeckle, M.Y., and Hanafusa, H. (1990) Genes & Dev. 4, 243- 254). The close relationship or identity between EFI, CBF, and NF-Y, thus has important implications regarding the mechanisms by which serum or the oncogene v-src may affect changes in gene expression.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
CVIHome page
L. Shao and K. Sperber
Impaired Regulation of HLA-DR Expression in Human Immunodeficiency Virus-Infected Monocytes
Clin. Vaccine Immunol., July 1, 2002; 9(4): 739 - 746.
[Full Text] [PDF]


Home page
J. Biol. Chem.Home page
P. S. Holm, S. Bergmann, K. Jurchott, H. Lage, K. Brand, A. Ladhoff, K. Mantwill, D. T. Curiel, M. Dobbelstein, M. Dietel, et al.
YB-1 Relocates to the Nucleus in Adenovirus-infected Cells and Facilitates Viral Replication by Inducing E2 Gene Expression through the E2 Late Promoter
J. Biol. Chem., March 15, 2002; 277(12): 10427 - 10434.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. Rakoff-Nahoum, H. Chen, T. Kraus, I. George, E. Oei, M. Tyorkin, E. Salik, P. Beuria, and K. Sperber
Regulation of Class II Expression in Monocytic Cells after HIV-1 Infection
J. Immunol., August 15, 2001; 167(4): 2331 - 2342.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
L. Zhao, M. A. Cissell, E. Henderson, R. Colbran, and R. Stein
The RIPE3b1 Activator of the Insulin Gene Is Composed of a Protein(s) of Approximately 43 kDa, Whose DNA Binding Activity Is Inhibited by Protein Phosphatase Treatment
J. Biol. Chem., March 31, 2000; 275(14): 10532 - 10537.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
C. M. Mobley and L. Sealy
Role of the Transcription Start Site Core Region and Transcription Factor YY1 in Rous Sarcoma Virus Long Terminal Repeat Promoter Activity
J. Virol., August 1, 1998; 72(8): 6592 - 6601.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
A. Nambiar, S. K. Swamynathan, J. C. Kandala, and R. V. Guntaka
Characterization of the DNA-Binding Domain of the Avian Y-Box Protein, chkYB-2, and Mutational Analysis of Its Single-Strand Binding Motif in the Rous Sarcoma Virus Enhancer
J. Virol., February 1, 1998; 72(2): 900 - 909.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. R. B. de Medeiros, G. Krey, A. K. Hihi, and W. Wahli
Functional Interactions between the Estrogen Receptor and the Transcription Activator Sp1 Regulate the Estrogen-dependent Transcriptional Activity of the Vitellogenin A1 io Promoter
J. Biol. Chem., July 18, 1997; 272(29): 18250 - 18260.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K.-i. Tezuka, D. T. Denhardt, G. A. Rodan, and S.-i. Harada
Stimulation of Mouse Osteopontin Promoter by v-Src Is Mediated by a CCAAT Box-binding Factor
J. Biol. Chem., September 13, 1996; 271(37): 22713 - 22717.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. K. Sapru, J. P. Gao, W. Walke, M. Burmeister, and D. Goldman
Cloning and Characterization of a Novel Transcriptional Repressor of the Nicotinic Acetylcholine Receptor [IMAGE]-Subunit Gene
J. Biol. Chem., March 22, 1996; 271(12): 7203 - 7211.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. L. Wright, T. L. Moore, B. J. Vilen, A. M. Brown, and , J. P.-Y. Ting
Major Histocompatibility Complex Class II-associated Invariant Chain Gene Expression Is Up-regulated by Cooperative Interactions of Sp1 and NF-Y
J. Biol. Chem., September 8, 1995; 270(36): 20978 - 20986.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
G. H. MacDonald, Y. Itoh-Lindstrom, and J. P.-Y. Ting
The Transcriptional Regulatory Protein, YB-1, Promotes Single-stranded Regions in the DRA Promoter
J. Biol. Chem., February 24, 1995; 270(8): 3527 - 3533.
[Abstract] [Full Text] [PDF]


Home page
Genes Dev.Home page
S R Hann, M Dixit, R C Sears, and L Sealy
The alternatively initiated c-Myc proteins differentially regulate transcription through a noncanonical DNA-binding site.
Genes & Dev., October 15, 1994; 8(20): 2441 - 2452.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 1990 by the American Society for Biochemistry and Molecular Biology.